| Response |
NPLS (175 mg/m2) N(%) |
NPLS (80 mg/m2) N (%) |
Taxol® (175 mg/m2) N(%) |
| Complete Response |
3 (6.8) |
0 |
0 |
| Partial Response |
13 (29.6) |
20 (46.5) |
5 (20.8) |
| Overall Response Rate |
16 (36.4) |
20 (46.5) |
5 (20.8) |
| Stable Disease |
22 (50) |
18 (41.9) |
15 (62.5) |
| Disease Control Rate |
38 ( 86.4) |
38 (88.4) |
20 (83.3) |
|
| * 111 patients qualified for per protocol population for efficacy analysis. |
| Table 3: Response to Nanosomal Paclitaxel Lipid Suspension (NPLS) or Taxol® (n=111)*. |
